C
Clarity Pharmaceuticals Ltd
ASX:CU6
Clarity Pharmaceuticals Ltd
ASX:CU6
Price:
2.745
AUD
-7.26%
Market Closed
Market Cap:
AU$1B
Balance Sheet
Balance Sheet Decomposition
Clarity Pharmaceuticals Ltd
Clarity Pharmaceuticals Ltd
Balance Sheet Decomposition is not available for
Clarity Pharmaceuticals Ltd
Clarity Pharmaceuticals Ltd
Balance Sheet
Clarity Pharmaceuticals Ltd
Clarity Pharmaceuticals Ltd
Currency: AUD
| Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
5
|
8
|
55
|
31
|
48
|
48
|
|
| Cash |
5
|
8
|
30
|
6
|
33
|
18
|
|
| Cash Equivalents |
0
|
0
|
25
|
25
|
15
|
29
|
|
| Short-Term Investments |
1
|
11
|
37
|
34
|
89
|
36
|
|
| Total Receivables |
3
|
3
|
7
|
10
|
13
|
10
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Receivables |
0
|
0
|
7
|
10
|
12
|
10
|
|
| Other Current Assets |
0
|
0
|
1
|
2
|
5
|
6
|
|
| Total Current Assets |
9
|
23
|
100
|
77
|
154
|
101
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
9
N/A
|
23
+148%
|
100
+341%
|
77
-23%
|
155
+101%
|
101
-35%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
3
|
3
|
2
|
3
|
|
| Accrued Liabilities |
0
|
0
|
1
|
1
|
2
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
2
|
4
|
4
|
4
|
5
|
|
| Total Current Liabilities |
1
|
2
|
8
|
8
|
8
|
10
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Liabilities |
1
N/A
|
2
+144%
|
8
+225%
|
8
+2%
|
8
+8%
|
11
+31%
|
|
| Equity | |||||||
| Common Stock |
24
|
45
|
132
|
133
|
249
|
256
|
|
| Retained Earnings |
16
|
25
|
40
|
64
|
103
|
166
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
8
N/A
|
20
+149%
|
92
+355%
|
69
-25%
|
146
+111%
|
90
-38%
|
|
| Total Liabilities & Equity |
9
N/A
|
23
+148%
|
100
+341%
|
77
-23%
|
155
+101%
|
101
-35%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
256
|
257
|
259
|
261
|
312
|
321
|
|
Switch to:
Switch to:
See Also
Discover More
